| Autor: |
Luizaga CTM; Diretoria de Informação e Epidemiologia, Fundação Oncocentro de São Paulo, São Paulo, SP, Brasil., Ribeiro KB; Departamento de Saúde Coletiva, Faculdade de Ciências Médicas, Santa Casa de São Paulo, São Paulo, SP, Brasil., Fonseca LAM; Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil., Eluf Neto J; Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. |
| Jazyk: |
Portuguese; English |
| Zdroj: |
Revista de saude publica [Rev Saude Publica] 2020; Vol. 54, pp. 87. Date of Electronic Publication: 2020 Aug 28. |
| DOI: |
10.11606/s1518-8787.2020054001948 |
| Abstrakt: |
OBJECTIVE To estimate the magnitude and identify patterns of change in prostate cancer mortality in the state of São Paulo and in the 17 regional health care networks, according to age groups from 50 years onwards, in the period between 2000 to 2015. METHODS Age-adjusted mortality rates (per 100,000 men) were calculated by the direct method using the Segi world population as standard. Joinpoint regression was used to calculate the average annual percent change (AAPC), with a confidence interval of 95% (95%CI), by regional network and age group (50-59, 60-69, 70-79 and 80 years or more). RESULTS For the state of São Paulo, age-adjusted mortality rates were 15.2, 13.3 and 11.9 per 100,000 men, respectively, in the periods between 2000 to 2005, 2006 to 2010 and 2011 to 2015, with a significant decrease trend (AAPC = -2.10%; 95%CI -2.42 - -1.79) each year. Among the 17 networks, 11 presented significant mean annual reductions, ranging from -1.72% to -3.05%. From the age of 50 onwards, there was a sharper reduction in the groups from 50 to 59 (AAPC = -2.33%; 95%CI -3.04 - -1.62) and 60 to 69 years (AAPC = -2.84%; 95%CI - 3.25 - -2.43). CONCLUSION Although reductions in mortality are still slight, they indicate progress in prostate cancer control actions. Screening actions and changes in therapeutic behaviors in recent decades may be modifying incidence and survival, resulting in changes in the mortality profile. More detailed studies will be useful in understanding the factors that lead to the interregional variations found. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
